Application
Nutlin-3 has been used:
- as a drug to stimulate p53 functions in gene transfer experiment
- to inject worms to verify the prevalent role of translationally controlled tumor protein (TCTP) in posterior amputated E. eugeniae
- as a p53 activator in cyclotherapy studies
- as an mdm2 inhibitor to know its effect on p53 levels, cleaved caspase 3 and Poly (ADP-ribose) polymerase (PARP) cleavage
Biochem/physiol Actions
Nutlin-3, an antagonist of a human homolog of murine double minute 2 (HDM2). It has the ability to inhibit the HDM2-directed degradation of p53. Nutlin-3 can also enhance the transcriptional activities of p73.
Nutlin-3 is a Mdm2 (mouse double minute 2) antagonist, p53 pathway activator, and apoptosis inducer.
Features and Benefits
This compound is a featured product for Apoptosis research. Click here to discover more featured Apoptosis products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.
This compound was developed by Roche. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Other Notes
Relative stereochemistry; racemic mixture of (4R, 5S) and (4S, 5R) enantiomers.
Analysis Note
relative stereochemistry
Legal Information
Sold under license from Hoffman-La Roche, Inc. US patent 6,734,302.
- UPC:
- 51142509
- Condition:
- New
- HazmatClass:
- No
- MPN:
- N6287-1MG
- CAS:
- 548472-68-0
- Temperature Control Device:
- Yes
akash.verma@cenmed.com
(732) 447-1115





